Abstract:Natural amino donation: A PLP-dependent aminotransferase PctV, encoded in the pactamycin biosynthetic gene cluster, was found to catalyze the formation of 3-aminobenzoate from 3-dehydroshikimate with L-glutamate as the amino donor. The PctV reaction comprises a transamination and two dehydration reactions. This is the first report of a simple 3-ABA synthase in nature.
“…Recently, a 3AB biosynthetic pathway was identified, which employs an aminotransferase/3AB synthase to convert 3‐dehydroshikimic acid (DHS) to 3AB using L‐glutamic acid as the amino donor . Notably, DHS is a key intermediate of the shikimate pathway that is ubiquitously used by bacteria, algae, fungi and plants for making aromatic amino acids .…”
3-amino-benzoic acid (3AB) is an important building block molecule for production of a wide range of important compounds such as natural products with various biological activities. In the present study, we established a microbial biosynthetic system for de novo 3AB production from the simple substrate glucose. First, the active 3AB biosynthetic pathway was reconstituted in the bacterium Escherichia coli, which resulted in the production of 1.5 mg/L 3AB. In an effort to improve the production, an E. coli-E. coli co-culture system was engineered to modularize the biosynthetic pathway between an upstream strain and an downstream strain. Specifically, the upstream biosynthetic module was contained in a fixed E. coli strain, whereas a series of E. coli strains were engineered to accommodate the downstream biosynthetic module and screened for optimal production performance. The best co-culture system was found to improve 3AB production by 15 fold, compared to the mono-culture approach. Further engineering of the co-culture system resulted in biosynthesis of 48 mg/L 3AB. Our results demonstrate co-culture engineering can be a powerful new approach in the broad field of metabolic engineering.
“…Recently, a 3AB biosynthetic pathway was identified, which employs an aminotransferase/3AB synthase to convert 3‐dehydroshikimic acid (DHS) to 3AB using L‐glutamic acid as the amino donor . Notably, DHS is a key intermediate of the shikimate pathway that is ubiquitously used by bacteria, algae, fungi and plants for making aromatic amino acids .…”
3-amino-benzoic acid (3AB) is an important building block molecule for production of a wide range of important compounds such as natural products with various biological activities. In the present study, we established a microbial biosynthetic system for de novo 3AB production from the simple substrate glucose. First, the active 3AB biosynthetic pathway was reconstituted in the bacterium Escherichia coli, which resulted in the production of 1.5 mg/L 3AB. In an effort to improve the production, an E. coli-E. coli co-culture system was engineered to modularize the biosynthetic pathway between an upstream strain and an downstream strain. Specifically, the upstream biosynthetic module was contained in a fixed E. coli strain, whereas a series of E. coli strains were engineered to accommodate the downstream biosynthetic module and screened for optimal production performance. The best co-culture system was found to improve 3AB production by 15 fold, compared to the mono-culture approach. Further engineering of the co-culture system resulted in biosynthesis of 48 mg/L 3AB. Our results demonstrate co-culture engineering can be a powerful new approach in the broad field of metabolic engineering.
“…34−39 BtrR, a dual functional aminotransferase for the biosynthesis of 2-DOS in butirosin, has also been biochemically and structurally characterized. 40,41 Surprisingly, limited examples were available on the biochemical and structural characterization of aminotransferases responsible for scaffold construction/modification in the biosynthesis of bacterial secondary metabolites, including OxyQ (anhydrotetracycline, in vivo studies), 42 Neo-18 (neomycin) and BtrB (butirosin), 43 PvdH (pyoverdinesiderophore), 44 YwfG (anticapsin), 45 PctV (pactamycin), 46,47 and GenS2 (gentamycin). 48 The crystal structure of PigE, 49 an aminotransferase in prodigiosin biosynthesis, 50 was recently reported.…”
“…Further, PctL (PtmJ) was characterized as a glycosyltransferase that catalyzes transglycosylation between UDP‐ N ‐acetyl‐ d ‐glucosamine (UDP‐GlcNAc) and 3AAP to produce N ‐acetyl‐ d ‐glucosaminyl‐3‐aminoacetophenone (GlcNAc‐3AAP, 2 ) . However, 3AAP was not incorporated into pactamycin; this indicated that the physiological substrate of PctL was 3ABA or its thioester derivatives such as 3‐aminophenyl‐β‐oxopropanoic acid thioester, which would undergo hydrolysis and decarboxylation to give the 3AAP moiety . Mahmud and co‐workers reported that a mutant with a knockout of a discrete acyl carrier protein PtmL (PctK) did not accumulate any pactamycin biosynthetic intermediates .…”
The unique five-membered aminocyclitol core of the antitumor antibiotic pactamycin originates from d-glucose, so unprecedented enzymatic modifications of the sugar intermediate are involved in the biosynthesis. However, the order of the modification reactions remains elusive. Herein, we examined the timing of introduction of an amino group into certain sugar-derived intermediates by using recombinant enzymes that were encoded in the pactamycin biosynthesis gene cluster. We found that the NAD -dependent alcohol dehydrogenase PctP and pyridoxal 5'-phosphate dependent aminotransferase PctC converted N-acetyl-d-glucosaminyl-3-aminoacetophonone into 3'-amino-3'-deoxy-N-acetyl-d-glucosaminyl-3-aminoacetophenone. Further, N-acetyl-d-glucosaminyl-3-aminophenyl-β-oxopropanoic acid ethyl ester was converted into the corresponding 3'-amino derivative. However, PctP did not oxidize most of the tested d-glucose derivatives, including UDP-GlcNAc. Thus, modification of the GlcNAc moiety in pactamycin biosynthesis appears to occur after the glycosylation of aniline derivatives.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.